Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Double-membrane filtration method for microbiological testing of pharmaceuticals

A technology of microbiological testing and filtering method, applied in the field of drug microbiological testing, can solve the problems of patients' health and life safety threats, the test cannot be continued, and microbial contamination, etc., and achieve the effect of simple and feasible method, effective results, and elimination of bacteriostatic activity.

Active Publication Date: 2016-06-15
SHANDONG INST FOR FOOD & DRUG CONTROL
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are certain defects in this technology at present: some drug test solutions contain carbomer, cellulose derivatives, colloidal silicon, calcium soap and insoluble drug residues, etc., often block the filter membrane during the test (the national standard stipulates that the filter Membrane pore size is not greater than 0.45μm), which makes the test unable to continue
However, due to the flaws in the method, some of the drugs contaminated by microorganisms, especially the low-level contamination, passed the test results and entered the clinic, posing a serious threat to the health of patients and even their lives.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Double-membrane filtration method for microbiological testing of pharmaceuticals
  • Double-membrane filtration method for microbiological testing of pharmaceuticals
  • Double-membrane filtration method for microbiological testing of pharmaceuticals

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Take the sterility test of ganciclovir ophthalmic gel as an example.

[0031] 1. Medium and reagents: thioglycolate fluid medium, modified Martin medium, nutrient broth medium, nutrient agar medium, rose bengal sodium agar medium, 0.1% peptone buffer, anhydrous calcium chloride.

[0032] 2. Test sample: Ganciclovir ophthalmic gel.

[0033] 3. Experimental strains: Bacillus subtilis [CMCC (B) 63501], Escherichia coli [CMCC (B) 44102], Staphylococcus aureus [CMCC (B) 26003]; Clostridium sporogenes [CMCC (B) 64941], Candida albicans [CMCC(F)98001], and Aspergillus niger [CMCC(F)98003] were all provided by the China Institute for Food and Drug Identification.

[0034] 4. Bacterial solution preparation: Escherichia coli, Staphylococcus aureus, and Bacillus subtilis use nutrient broth medium, Clostridium sporogenes use thioglycolate fluid medium, culture at 30-35°C for 18-24 hours; white Candida adopts modified Martin's medium and cultures at 20-25°C for 24-48 hours; Asperg...

Embodiment 2

[0044] Take the microbial limit test of compound berberine tablets as an example.

[0045] 1. Instruments BSC-1500IIA2-X biological clean safety cabinet; MJ-250I mold incubator, GHP-9270 water-proof constant temperature incubator; SartoriusCP225D electronic balance; YT-X301 microbial limit tester.

[0046] 2. The test product compound Andrographis lotus tablets.

[0047]3. Bacillus subtilis (Bacillus subtilis) [CMCC (B) 63501]; Escherichia coli (Escherichiacoli) [CMCC (B) 44102]; Staphylococcus aureus (Staphylococcus aureus) [CMCC (B) 26003]; Candida albicans Candida albicans [CMCC (F) 98001]; Aspergillus niger (Aspergillus niger) [CMCC (F) 98003] are all from the Medical Culture Collection Center of China Institute for the Control of Pharmaceutical and Biological Products. .

[0048] 4. Culture medium Nutrient agar medium, lot number 101021; rose bengal sodium agar medium, lot number 1001122pH7.0 sodium chloride-peptone buffer, lot number 110421; all purchased from Beijing ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
pore sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a double-membrane filtration method for microbial inspection of pharmaceuticals. Two-layer filter membranes are used. The pore size of the first filter membrane can be 5 μm-10 μm, 10 μm-20 μm, 20 μm-30 μm, and 30 μm-50 μm. Insoluble substances such as macromolecular matrix, particles, fibers, and drug residues; the pore size of the second filter membrane is not greater than 0.45 μm, which is used to retain microorganisms. The method of the invention can effectively prevent the clogging of the filter membrane, is beneficial to eliminate the antibacterial activity of the test product, and avoids the damage of the polluting microorganisms in the test product. The method of the present invention can be used to test the medicines that cannot be effectively tested by the current method. It is proved by a large number of test data that the method is simple and feasible, and the result is effective.

Description

technical field [0001] The invention relates to the field of drug microbiological testing, in particular to a double-membrane filtration method for drug microbiological testing. Background technique [0002] Microbial contamination is one of the main causes of adverse drug events. Preventing contaminated drugs from entering the market is of great significance for ensuring the safety of patients. In the microbiological inspection of pharmaceuticals, whether the microorganisms in the microcosm can be detected, the inspection method is very important. Membrane filtration technology is an important technology for collecting microorganisms in the field of pharmaceutical microbial inspection. For drugs with antibacterial activity, it is necessary to use membrane filtration to fully eliminate the antibacterial activity of the drug, so as to facilitate the recovery, reproduction and detection of dormant or damaged microorganisms in the drug. However, there are certain defects in t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/04
Inventor 史国生丁勃王志宏冷佳蔚徐晓洁李军国明
Owner SHANDONG INST FOR FOOD & DRUG CONTROL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products